Literature DB >> 24855005

Microbiome, inflammation, and cancer.

Ralph Francescone1, Vivianty Hou, Sergei I Grivennikov.   

Abstract

Inflammation has long been suspected to play a major role in the pathogenesis of cancer. Only recently, however, have some mechanisms of its tumor promoting effects become known. Microbes, both commensal and pathogenic, are critical regulators of the host immune system and, ultimately, of inflammation. Consequently, microbes have the potential power to influence tumor progression as well, through a wide variety of routes, including chronic activation of inflammation, alteration of tumor microenvironment, induction of genotoxic responses, and metabolism. In this review, we will provide a general overview of commensal microbiota, inflammation, and cancer, as well as how microbes fit into this emerging field.

Entities:  

Mesh:

Year:  2014        PMID: 24855005      PMCID: PMC4112188          DOI: 10.1097/PPO.0000000000000048

Source DB:  PubMed          Journal:  Cancer J        ISSN: 1528-9117            Impact factor:   3.360


  96 in total

Review 1.  Inflammation and colorectal cancer: colitis-associated neoplasia.

Authors:  Sergei I Grivennikov
Journal:  Semin Immunopathol       Date:  2012-11-16       Impact factor: 9.623

2.  Non-steroidal anti-inflammatory drugs and colorectal cancer risk in a large, prospective cohort.

Authors:  Elizabeth H Ruder; Adeyinka O Laiyemo; Barry I Graubard; Albert R Hollenbeck; Arthur Schatzkin; Amanda J Cross
Journal:  Am J Gastroenterol       Date:  2011-03-15       Impact factor: 10.864

Review 3.  Neutralizing tumor-promoting chronic inflammation: a magic bullet?

Authors:  Lisa M Coussens; Laurence Zitvogel; A Karolina Palucka
Journal:  Science       Date:  2013-01-18       Impact factor: 47.728

4.  Intestinal inflammation targets cancer-inducing activity of the microbiota.

Authors:  Janelle C Arthur; Ernesto Perez-Chanona; Marcus Mühlbauer; Sarah Tomkovich; Joshua M Uronis; Ting-Jia Fan; Barry J Campbell; Turki Abujamel; Belgin Dogan; Arlin B Rogers; Jonathan M Rhodes; Alain Stintzi; Kenneth W Simpson; Jonathan J Hansen; Temitope O Keku; Anthony A Fodor; Christian Jobin
Journal:  Science       Date:  2012-08-16       Impact factor: 47.728

5.  Interleukin-10-deficient mice develop chronic enterocolitis.

Authors:  R Kühn; J Löhler; D Rennick; K Rajewsky; W Müller
Journal:  Cell       Date:  1993-10-22       Impact factor: 41.582

6.  Commensal bacteria influence Escherichia coli O157:H7 persistence and Shiga toxin production in the mouse intestine.

Authors:  Shantini D Gamage; Angela K Patton; Jane E Strasser; Claudia L Chalk; Alison A Weiss
Journal:  Infect Immun       Date:  2006-03       Impact factor: 3.441

7.  Helicobacter pylori eradication prevents progression of gastric cancer in hypergastrinemic INS-GAS mice.

Authors:  Chung-Wei Lee; Barry Rickman; Arlin B Rogers; Zhongming Ge; Timothy C Wang; James G Fox
Journal:  Cancer Res       Date:  2008-04-25       Impact factor: 12.701

8.  Suppression of Tumorigenicity-14, encoding matriptase, is a critical suppressor of colitis and colitis-associated colon carcinogenesis.

Authors:  P Kosa; R Szabo; A A Molinolo; T H Bugge
Journal:  Oncogene       Date:  2011-12-05       Impact factor: 9.867

9.  Substantial alterations of the cutaneous bacterial biota in psoriatic lesions.

Authors:  Zhan Gao; Chi-hong Tseng; Bruce E Strober; Zhiheng Pei; Martin J Blaser
Journal:  PLoS One       Date:  2008-07-23       Impact factor: 3.240

Review 10.  Colonization resistance: battle of the bugs or Ménage à Trois with the host?

Authors:  Alanna M Spees; Christopher A Lopez; Dawn D Kingsbury; Sebastian E Winter; Andreas J Bäumler
Journal:  PLoS Pathog       Date:  2013-11-21       Impact factor: 6.823

View more
  78 in total

Review 1.  Human microbiome and prostate cancer development: current insights into the prevention and treatment.

Authors:  Solmaz Ohadian Moghadam; Seyed Ali Momeni
Journal:  Front Med       Date:  2020-06-30       Impact factor: 4.592

Review 2.  Diabetes, Obesity, and Breast Cancer.

Authors:  Chifei Kang; Derek LeRoith; Emily J Gallagher
Journal:  Endocrinology       Date:  2018-11-01       Impact factor: 4.736

3.  Elevated peripheral inflammatory markers are related with the recurrence and canceration of vocal fold leukoplakia.

Authors:  Yi Fang; Yue Yang; Min Chen; Peijie He; Lei Cheng; Jian Chen; Haitao Wu
Journal:  Eur Arch Otorhinolaryngol       Date:  2019-07-31       Impact factor: 2.503

Review 4.  The Intestinal Microbiome and Estrogen Receptor-Positive Female Breast Cancer.

Authors:  Maryann Kwa; Claudia S Plottel; Martin J Blaser; Sylvia Adams
Journal:  J Natl Cancer Inst       Date:  2016-04-22       Impact factor: 13.506

Review 5.  Gnotobiotic mouse model's contribution to understanding host-pathogen interactions.

Authors:  Klara Kubelkova; Milota Benuchova; Hana Kozakova; Marek Sinkora; Zuzana Krocova; Jaroslav Pejchal; Ales Macela
Journal:  Cell Mol Life Sci       Date:  2016-08-20       Impact factor: 9.261

6.  Anti-inflammatory natural product goniothalamin reduces colitis-associated and sporadic colorectal tumorigenesis.

Authors:  Débora Barbosa Vendramini-Costa; Ralph Francescone; David Posocco; Vivianty Hou; Oxana Dmitrieva; Harvey Hensley; João Ernesto de Carvalho; Ronaldo Aloise Pilli; Sergei I Grivennikov
Journal:  Carcinogenesis       Date:  2016-10-24       Impact factor: 4.944

7.  Inflammatory dietary pattern and incident psoriasis, psoriatic arthritis, and atopic dermatitis in women: A cohort study.

Authors:  Alanna C Bridgman; Abrar A Qureshi; Tricia Li; Fred K Tabung; Eunyoung Cho; Aaron M Drucker
Journal:  J Am Acad Dermatol       Date:  2019-02-21       Impact factor: 11.527

8.  Co-expression of TLR-9 and MMP-13 is associated with the degree of tumour differentiation in prostate cancer.

Authors:  Elham Kalantari; Maryam Abolhasani; Raheleh Roudi; Mohammad M Farajollahi; Seif Farhad; Zahra Madjd; Shaghayegh Askarian-Amiri; Monireh Mohsenzadegan
Journal:  Int J Exp Pathol       Date:  2019-05-14       Impact factor: 1.925

Review 9.  NF-κB, inflammation, immunity and cancer: coming of age.

Authors:  Koji Taniguchi; Michael Karin
Journal:  Nat Rev Immunol       Date:  2018-01-22       Impact factor: 53.106

Review 10.  Microbiome and potential targets for chemoprevention of esophageal adenocarcinoma.

Authors:  Antonio Galvao Neto; April Whitaker; Zhiheng Pei
Journal:  Semin Oncol       Date:  2015-09-07       Impact factor: 4.929

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.